WallStreetZenWallStreetZen

NASDAQ: SERA
Sera Prognostics Inc Stock

$2.10+0.10 (+5%)
Updated Dec 5, 2023
Why Price Moved
SERA Price
$2.10
Fair Value Price
$2.98
Market Cap
$65.81M
52 Week Low
$1.10
52 Week High
$4.25
P/E
-1.71x
P/B
0.87x
P/S
176.34x
PEG
N/A
Dividend Yield
N/A
Revenue
$330.00k
Earnings
-$38.06M
Gross Margin
25.8%
Operating Margin
-11,515.45%
Profit Margin
-11,534.2%
Debt to Equity
0.19
Operating Cash Flow
-$28M
Beta
0.88
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

SERA Overview

Sera Prognostics Incorporated is a women's health diagnostic company. It offers biomarker tests for improving pregnancy outcomes by testing for preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. PreTRM, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies, was one of the company's first successes. Sera Prognostics was incorporated in 2008 and is headquartered in Salt Lake City, UT.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SERA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SERA ($2.10) is undervalued by 29.46% relative to our estimate of its Fair Value price of $2.98 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SERA ($2.10) is significantly undervalued by 29.46% relative to our estimate of its Fair Value price of $2.98 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
SERA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SERA due diligence checks available for Premium users.

Be the first to know about important SERA news, forecast changes, insider trades & much more!

SERA News

Valuation

SERA fair value

Fair Value of SERA stock based on Discounted Cash Flow (DCF)
Price
$2.10
Fair Value
$2.98
Undervalued by
29.46%
SERA ($2.10) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SERA ($2.10) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SERA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SERA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.71x
Industry
31.51x
Market
30.4x

SERA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.87x
Industry
3.92x
SERA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SERA's financial health

Profit margin

Revenue
$42.0k
Net Income
-$7.2M
Profit Margin
-17,166.7%
SERA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SERA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$90.1M
Liabilities
$14.6M
Debt to equity
0.19
SERA's short-term assets ($47.55M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SERA's short-term assets ($47.55M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SERA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$7.6M
Investing
-$15.2M
Financing
$128.0k
SERA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SERA vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
SERA$65.81M+5.00%-1.71x0.87x
ENZ$62.61M-1.59%3.02x0.80x
ACRS$69.84M+0.31%-0.59x0.45x
NOTV$70.90M-2.48%-0.20x0.26x
DMTK$56.84M+9.21%-0.47x0.78x

Sera Prognostics Stock FAQ

What is Sera Prognostics's quote symbol?

(NASDAQ: SERA) Sera Prognostics trades on the NASDAQ under the ticker symbol SERA. Sera Prognostics stock quotes can also be displayed as NASDAQ: SERA.

If you're new to stock investing, here's how to buy Sera Prognostics stock.

What is the 52 week high and low for Sera Prognostics (NASDAQ: SERA)?

(NASDAQ: SERA) Sera Prognostics's 52-week high was $4.25, and its 52-week low was $1.10. It is currently -50.59% from its 52-week high and 90.91% from its 52-week low.

How much is Sera Prognostics stock worth today?

(NASDAQ: SERA) Sera Prognostics currently has 31,336,512 outstanding shares. With Sera Prognostics stock trading at $2.10 per share, the total value of Sera Prognostics stock (market capitalization) is $65.81M.

Sera Prognostics stock was originally listed at a price of $11.90 in Jul 15, 2021. If you had invested in Sera Prognostics stock at $11.90, your return over the last 2 years would have been -82.35%, for an annualized return of -57.99% (not including any dividends or dividend reinvestments).

How much is Sera Prognostics's stock price per share?

(NASDAQ: SERA) Sera Prognostics stock price per share is $2.10 today (as of Dec 5, 2023).

What is Sera Prognostics's Market Cap?

(NASDAQ: SERA) Sera Prognostics's market cap is $65.81M, as of Dec 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Sera Prognostics's market cap is calculated by multiplying SERA's current stock price of $2.10 by SERA's total outstanding shares of 31,336,512.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.